Pune, India, September, 2018 /press release/- Market Research Future Published a Half-Cooked Research Report on Larvicides Market Research Report.
The global larvicides market has been segmented by type, form, target, application, and region.
By type, the global larvicides market has been divided into microbial larvicides, organophosphates, insect growth regulators, and others. Microbial larvicides are formulated to deliver a natural toxin to the intended target organisms and are, therefore, environmentally friendly. Some of the bacteria used as larvicides include Bacillus sphaericus, Bacillus thuringiensis, and Romanomermis culicivorax. However, these are effective for a short period of time and are re-introduced every 15 days. Additionally, fishes such as Gambusia affinis (mosquito fish) and Poecilia reticulate (common guppy) can be effectively used to control the mosquito population.
On the basis of type, the market has been segregated into liquids, tablets, pellets, granules, and briquettes. The liquid form of larvicides is highly preferred due to their ease of application and effectiveness.
Based on target, the market has been divided into mosquitoes and flies. The mosquitoes segment accounted for the majority market share in 2017 due to the high number of diseases carried by them such as chikungunya, dengue fever, lymphatic filariasis, Zika, malaria, Lyme disease, West Nile, and Chagas’ disease.
By application, the market has been segmented into public health, agriculture, commercial, residential, and livestock. The public health segment accounted for the largest market share in 2017. This can be attributed to climatic changes and population mobility resulting in favorable environments for pest growth.
The larvicides market has been analyzed with respect to five regions, namely, Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa.
The market in North America dominated the global larvicides market in 2017 on account of the increasing prevalence of vector-borne diseases in the region.
Increasing health awareness among citizens coupled with the high spending on healthcare in Europe is expected to drive product demand in the region during the forecast period.
The market in Asia-Pacific is expected to grow substantially due to the increasing prevalence of vector-borne diseases coupled with the high product demand in the agriculture industry in the region.
Some of the manufacturers operating in the global larvicides market are Bayer AG (Germany), BASF SE (Germany), Syngenta (Switzerland), Sumitomo Chemical Co., Ltd (Japan), Adama Agan Ltd (Israel), Certis USA LLC (US), Central Garden & Pet Company (US), Nufarm Limited (Australia), Russell IPM Ltd (UK), Gowan Company (US), Isagro (Italy), and Arysta LifeScience Corporation (US).